Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder (ALEXART)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: ANAIS MOREAU
- Phone Number: 02.41.35.37.72
- Email: Anais.Moreau@chu-angers.fr
Study Contact Backup
- Name: LAURENT SAMSON
- Phone Number: 06.65.80.75.82
- Email: LaSamson@chu-angers.fr
Study Locations
-
-
-
Angers, France, 49033
- Recruiting
- Centre Hospitalier Universitaire
-
Contact:
- ANAIS MOREAU
- Phone Number: 02 41 35 37 72
- Email: Anais.Moreau@chu-angers.fr
-
Contact:
- LAURENT SAMSON
- Email: LaSamson@chu-angers.fr
-
Principal Investigator:
- ANAIS MOREAU
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult 18 or over
- Patient with an alcohol use disorder starting day hospital care in the psychiatry and addiction department of the Angers University Hospital
- Subjects who gave and signed informed consent to participate in the study with alexithymia (Toronto Test greater than or equal to 56)
Exclusion Criteria:
- Non-understanding of the French language
- Non-affiliation to a social security scheme
- Major cognitive impairment
- Motor problems preventing walking
- Protective patients
- Pregnant or lactating women
- Patients under protection of justice or deprived of liberty
- Patients under protective supervision or guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
Standard support: information on alcoholic pathology, medico-psycho-social assessment, relapse prevention program
|
|
|
Experimental: Art-Therapy
in addition to standard treatment, art therapy treatment program: 1 session of 2 hours per week in a closed group for 10 weeks
|
1 session of 2 hours per week in a closed group for 10 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Echelle de Toronto (TAS)
Time Frame: 3 month after inclusion
|
self-questionnaire which includes 20 items and allows to measure 3 factors:
|
3 month after inclusion
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: BENEDICTE GOHIER, CHU ANGERS SERVICE DE PSYCHIATRIE ADDICTOLOGIE
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2017-A02031-52
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.